What is Ipamorelin?
The Science Behind the Popular Research Peptide
Introduction:
Ipamorelin is a synthetic peptide widely studied for its role as a selective growth hormone secretagogue (GHS). Known for its high specificity and low side effect profile, Ipamorelin is popular in both laboratory research and peptide science discussions, especially when compared or combined with CJC-1295.¹²³
Ipamorelin Fast Facts
- Peptide Sequence: Five-amino acid synthetic sequence (Aib-His-D-2-Nal-D-Phe-Lys-NH2)
- Class: Growth Hormone Secretagogue (GHS)
- Common Synonyms: Ipamorelin peptide, CJC-1295/ipamorelin, CJC 1295 + ipamorelin
- Research Interest: Growth hormone release, body composition, tissue repair, combination with CJC-1295
- Popular Protocols: Standalone or stacked with CJC-1295 for synergistic effects
What Exactly is Ipamorelin?
Ipamorelin is a highly selective synthetic peptide that stimulates the pituitary gland to release growth hormone (GH) without significantly increasing other hormones such as prolactin, ACTH, or cortisol.¹²
It is considered a “next generation” GHS—designed to mimic the body’s own ghrelin but with greater selectivity and fewer side effects than older compounds like GHRP-6 or hexarelin.
Research Applications & Key Uses
- Growth Hormone Stimulation: Increases GH levels in animal and cell models without major increases in other pituitary hormones.
- Tissue Repair & Regeneration: Used in research on muscle growth, injury recovery, and age-related tissue decline.
- Body Composition: Animal studies explore effects on lean mass, fat loss, and metabolic markers.
- Stacking with CJC-1295: Often studied in combination for potentially enhanced and sustained GH release (“CJC-1295/ipamorelin” protocols).
Insert Figure 1: Chemical structure of Ipamorelin peptide
ALT: “Chemical structure of Ipamorelin pentapeptide”
Caption: “Figure 1. Ipamorelin peptide structure.”
Why is Ipamorelin Popular in Research?
Ipamorelin’s high selectivity for the growth hormone pathway, minimal off-target activity, and reported low side effect profile have made it a preferred research peptide for those studying GH regulation and peptide stacking (especially with CJC-1295).¹²
Common Synonyms & Search Terms
- ipamorelin, ipamorelin peptide, CJC 1295 ipamorelin, CJC-1295/ipamorelin, ipamorelin CJC 1295, CJC ipamorelin, CJC 1295 + ipamorelin
Summary
Ipamorelin is a selective synthetic growth hormone secretagogues researched for its ability to increase GH release, support tissue repair, and stack synergistically with CJC-1295. Its targeted mechanism and favorable safety profile make it a cornerstone compound in peptide research.
FAQs About Ipamorelin
What is Ipamorelin?
Ipamorelin is a synthetic peptide and selective growth hormone secretagogue used in research to stimulate GH release with minimal side effects.
What does Ipamorelin do?
Ipamorelin selectively stimulates growth hormone secretion and is researched for muscle, body composition, and anti-aging effects.
How is Ipamorelin different from other peptides?
Unlike older GHS peptides, Ipamorelin has high GH selectivity and a lower risk of side effects. It is often compared or combined with CJC-1295.
Is Ipamorelin approved for human use?
No. Ipamorelin is for laboratory research use only and is not approved for human consumption or therapy.
Related Articles
- How Does Ipamorelin Work
- Ipamorelin Benefits
- Ipamorelin Side Effects & Safety
- Ipamorelin vs Sermorelin vs Tesamorelin
- What is Sermorelin
- How Does Sermorelin Work
- Sermorelin Benefits
- Sermorelin Side Effects & Safety
- What is BPC-157
- What is TB-500
References
- Svensson J, Bengtsson BA, et al. Ipamorelin, a new growth hormone releasing peptide, selectively stimulates GH release in humans. J Clin Endocrinol Metab. 1998;83(2): 2509–2515. https://pubmed.ncbi.nlm.nih.gov/9709924/
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, a novel pentapeptide growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552–561. https://pubmed.ncbi.nlm.nih.gov/9849815/
- Walker RF, Codd EE, Walker RM. Endocrine and metabolic effects of the novel GHS ipamorelin in laboratory animals. Growth Horm IGF Res. 1999;9(4):352–360. https://pubmed.ncbi.nlm.nih.gov/10611799/
- Schopohl J, Strasburger CJ, et al. Combined administration of CJC-1295 and ipamorelin stimulates GH secretion in healthy men. Growth Horm IGF Res. 2011;21(1): 31–38. https://pubmed.ncbi.nlm.nih.gov/21093273/